Omar Al-Mukhtar University

www.omu.edu.ly/
Libya

Omar Al-Mukhtar University , located in Bayda, started as an Islamic university. It was founded in 1835 by Ali al-Sanusi of the religious group 'Kzawip Senussi' in 1961. It has grown to be a moderately religious institute and teaches students the correct practises in regards to scripture reading and interpretation. OAMU educates students from many locations worldwide, including Malta, Cyprus, Egypt, Malaysia, Indonesia, Sudan and Chad.The Baksmha procedure room of OAMU is capable of housing thousands of students, although clashes between different religious sects has led to a shortage of experienced preachers and speakers. However, after the revolution, Fatih University has been rejected as a beacon to the Islamic Movement of mother-to-Senussi, a movement now banned in Libya.OAMU now belongs to the Faculty of Agriculture, the University of Garyounis is an independent and established university general in 1984. Follow the General People's Committee for Higher Education in the name of the campus now. Wikipedia.

SEARCH FILTERS
Time filter
Source Type

News Article | July 19, 2017
Site: www.reuters.com

GAZA (Reuters) - Ritta al-Jalees doesn't care who's to blame for the deteriorating state of healthcare in Gaza. All she wants is to ensure her three sons get the help they need to breathe. The boys, aged nine months and six and seven years, all of whom suffer from cystic fibrosis, are getting weaker because Gaza is running out of the drugs needed to treat the inherited lung disease and because of cuts to power for oxygen pumps and ventilators. "I blame all sides," said Jalees, a mother of six, as she held her youngest at Al-Rantissi Hospital for Children in Gaza City. "Are these children at fault?" Gaza has been under an Israeli blockade since 2007 after Hamas forces seized control of the territory following a brief civil war with security forces loyal to Mahmoud Abbas, the Western-backed Palestinian president based in the West Bank. Egypt, at odds with Hamas, also maintains a blockade. Although the Israeli blockage has eased somewhat in recent years, a new stage in the struggle between Abbas and the Islamist Hamas is turning the screws on the enclave afresh. In what is seen as the latest step in an effort to force Hamas to relinquish its control of Gaza, Abbas in June reduced the payments the PA makes to Israel for electricity it supplies to the territory. The resulting cuts mean that Gaza's two million people now have only 3 to 4 hours of power a day, forcing hospitals and other medical facilities to rely chiefly on generators and expensive fuel, while many private homes just go without. Hamas says that Abbas restricted transfers of medicine to Gaza in March, accusing Hamas of failing to reimburse the PA for its purchases, and cut the salaries of its officials in May. The spokesman for Gaza's Hamas-run health ministry, Ashraf Al-Qidra, said PA shipments of medicine, especially drugs to treat cancer and cystic fibrosis, have dropped 35 percent since late March. "We believe the actions of the Palestinian Authority and the Israeli occupation together are undermining the entire health service system in Gaza," Qidra told Reuters. Hamas also accuses the PA of delaying the transfer of hundreds of seriously ill patients to Israel or the Israeli-occupied West Bank, actions which it says has resulted in 13 deaths since April. The PA denies the allegations and accuses Israel of holding back permits. Israel denies the allegations. Whoever is at fault, a U.N. report released last week said power shortages are deepening a humanitarian crisis, with hospitals in a precarious condition, water shortages increasing and raw sewage being dumped into the Mediterranean because treatment plants aren't functioning. "The two million residents of Gaza are suffering through a humanitarian crisis that is entirely human-made," the report said. "It represents a complete failure of all parties to uphold their fundamental human rights obligations, including the inalienable right to life." Omar Al-Naser, director of media and public relations at the West Bank-based ministry of health, said Hamas' complaints were politically motivated. Hospitals in the West Bank were also suffering from drug shortages, he said. "Shortages in Gaza may happen, just like there are shortages in the north counties (West Bank), because there are debts the health ministry is trying to pay," he added. The Israeli government body that supervises civil activities in the Palestinian territories, the Coordination and Liaison Administration (CLA), said any holdup in patient transfers from Gaza was an internal Palestinian affair. "We would like to emphasize that in cases in which the Palestinian Authority sends requests, especially those defined as urgent, the Gaza CLA coordinates the crossing of patients immediately during every hour of the day in order to save lives," it said in a written response to Reuters. It said nearly 16,000 patients and escorts have been allowed to leave for hospitals in Israel and the West Bank so far in 2017, including 6,400 in the past three months. It also said it reduced power supplies to Gaza on a request from the Palestinian Authority. Cystic fibrosis causes the lungs and digestive system to become clogged with thick, sticky mucus. Over many years, the lungs and pancreas may eventually stop functioning. Gaza health officials say 320 people in the enclave have the disorder. Although it can be managed for years with regular visits to hospital, some sufferers in Gaza are now being admitted to hospital because of their worsening condition and because drugs there are cheaper and in some cases, free. Police officer Ashraf Shanty and his wife Jihan, who have two children with cystic fibrosis, started a charity in 2008 to help patients get medication and medical checks. Dozens of bags of medicines sit on a table next to breathing equipment in a room that Jihan Shanty, a medical laboratory technician, has turned into a mini-clinic in their home. One of the medicines in short supply is Creon. Made by the U.S. drugmaker AbbVie, it is used to treat a common condition in cystic fibrosis in which the sticky mucus prevents enzymes getting from the pancreas to the small intestine, where they would normally help break down food. "I have two sons suffering from the disease but I see myself as the father of 320 cystic fibrosis patients, whom I must help," Ashraf Shanty said. "Without Creon, the enzyme of life, they may die," he said.


Patent
Omar Al-Mukhtar University and Richardson | Date: 2017-07-05

A wine glass (30) comprising a bowl (31) connected to a stem (33) which is connected to a base (35), wherein the stem (33) is arranged to be movable relative to the bowl (31) between first and second configurations.


Patent
Da Ros, Geiger, Tamborini and Omar Al-Mukhtar University | Date: 2013-03-27

The invention relates to a portable charger for electronic devices (2) and to a corresponding charging method for recharging a DC battery (B2) of a portable electronic device (2) by means of a portable charger (3). The portable charger has a seat (5) for hosting at least a portion of said portable electronic device (2) and a source battery (B1) and a first coil (L1) of a transformer (6) are hosted in said portable charger (3). A secondary coil (L2) of the transformer (6) is hosted inside the portable electronic device (2) so that the first and secondary coils (L1, L2) being contactless coupled to charge said DC battery (B2) through the charge of said source battery (B1} when the portable electronic device (2) is hosted on the portable charger (3).


Patent
Smith, Parry, Carter, Clarke, Omar Al-Mukhtar University, Ferrazzini and Alfano | Date: 2012-04-11

A user equipment (UE) is disclosed comprising an agent configured to monitor and report UE configuration and capability information, wherein the UE is further configured to provide the UE configuration and capability information, and subsequently receive an application based on the configuration and capability information. Also disclosed is a network comprising a provisioning server configured to receive UE configuration and capability information, and subsequently provide an application based on the UE configuration and capability information. Also disclosed is a method comprising providing UE configuration and capability information from a UE, and receiving an application at the UE based on the configuration and capability information. Also disclosed is a method comprising receiving UE configuration and capability information at a provisioning server, and providing an application from the provisioning server based on the UE configuration and capability information.


Mohamed F.A.,Omar Al-Mukhtar University | Koivo H.N.,Aalto University
International Journal of Electrical Power and Energy Systems | Year: 2010

This paper presents a generalized formulation to determine the optimal operating strategy and cost optimization scheme for a MicroGrid. Prior to the optimization of the MicroGrid itself, models for the system components are determined using real data. The proposed cost function takes into consideration the costs of the emissions, NOx, SO2, and CO2, start-up costs, as well as the operation and maintenance costs. A daily income and outgo from sold or purchased power is also added. The MicroGrid considered in this paper consists of a wind turbine, a micro turbine, a diesel generator, a photovoltaic array, a fuel cell, and a battery storage. In this work, the Mesh Adaptive Direct Search (MADS) algorithm is used to minimize the cost function of the system while constraining it to meet the customer demand and safety of the system. In comparison with previously proposed techniques, a significant reduction is obtained. © 2009 Elsevier Ltd. All rights reserved.


Mohamed F.A.,Omar Al-Mukhtar University | Koivo H.N.,Aalto University
International Journal of Electrical Power and Energy Systems | Year: 2012

This paper presents a generalized formulation for determining the optimal operating strategy and cost optimization scheme and reduction of emissions of a MicroGrid (MG). Multiobjective (MO) optimization is applied to the environmental economic problem of the MG. The proposed problem is formulated as a nonlinear constrained MO optimization problem. The proposed problem takes into consideration the operation and maintenance costs as well as the emission reduction of NO x, SO 2, and CO 2. The MG considered in this paper consists of a wind turbine, a micro turbine, a diesel generator, a photovoltaic array, a fuel cell, and a battery storage. The Multiobjective Mesh Adaptive Direct Search (MOMADS) is employed to minimize the cost function of the system while constraining it to meet the costumer demand and safety of the system. A comparison is made with Multiobjective Sequential Quadratic Programming (MOSQP). The results demonstrate the efficiency of the proposed approach to satisfy the load and to reduce the cost and the emissions. © 2011 Elsevier Ltd. All rights reserved.


Mohamed F.A.,Omar Al-Mukhtar University | Koivo H.N.,Aalto University
Energy Conversion and Management | Year: 2012

This paper proposes a generalized formulation to determine the optimal operating strategy and cost optimization scheme for a MicroGrid (MG) for residential application. Genetic Algorithm is applied to the environmental/economic problem of the MG. The proposed problem is formulated as a nonlinear constrained MO optimization problem. Prior to the optimization of the microgrid itself, models for the system components are determined using real data. The proposed cost function takes into consideration the costs of the emissions, NOx, SO2, and CO2, start up costs, as well as the operation and maintenance costs. The MG considered in this paper consists of a wind turbine, a microturbine, a diesel generator, a photovoltaic array, a fuel cell, and a battery storage. The optimization is aimed at minimizing the cost function of the system while constraining it to meet the costumer demand and safety of the system. We also add a daily income and outgo from sale or purchased power. The results demonstrate the efficiency of the proposed approach to satisfy the load and to reduce the cost and the emissions. The comparison with other techniques demonstrates the superiority of the proposed approach and confirms its potential to solve the problem. © 2012 Elsevier Ltd. All rights reserved.


Hussein A.,Omar Al-Mukhtar University
Drug discoveries & therapeutics | Year: 2012

Cisplatin is a potent chemotherapeutic agent with a wide range of activities. Nephrotoxicity and cardiotoxicity represent it's major complication upon clinical use. The present study was carried out to evaluate the possible protective effect of DL-α-lipoic acid (LA) against cisplatin-induced nephrotoxicity and cardiotoxicity. Different groups of rats (n = 10) were administered either saline (control), cisplatin (10 mg/kg, i.p.), LA (100 mg/kg, i.p.) or their combination (LA 30 min prior to cisplatin administration). Twenty-four hours later all animals were decapitated and sera were used for estimation of activities of urea (BUN), creatinine (Cr), lactate dehydrogenase (LDH), and creatine kinase (CK). Homogenates of the kidney and heart were used for estimation of oxidative stress markers (reduced glutathione (GSH), malondialdehyde (MDA), superoxide dismutase (SOD), and nitric oxide (NO)). Additionally, caspase-3 activities and DNA-fragmentation were investigated in renal tissues. The results showed that cisplatin produced significant elevation in serum activities of LDH, CK, BUN, and Cr and also induced significant elevation in the oxidative stress makers (MDA and NO) accompanied by significant reduction in GSH and SOD in both kidney and heart. The integrity of DNA was heavily damaged and caspase-3 was activated in renal tissues. The results emphasized nephrotoxicty and cardiotoxicity of cisplatin. On the other hand, prior administration of LA significantly attenuated the cisplatin-evoked disturbances in the above mentioned parameters and protected both kidney and heart tissues. The histopathological examination emphasized the obtained results. In conclusion, LA is suggested to be a potential candidate to ameliorate cisplatin-induced nephrotoxicity and cardiotoxicity without altering the antitumor efficacy of cisplatin.


The effect of the charge and the nature of both the cations and the anions of some electrolytic salts: sodium fluoride (NaF), potassium fluoride (KF), sodium bromide (NaBr), potassium bromide (KBr), sodium iodide (NaI), potassium iodide (KI), sodium sulfate (Na2SO4), potassium sulfate (K2SO4), calcium chloride (CaCl2), and barium chloride (BaCl2), on the solubility of zwitterionic amino acids (glycine, DL-alanine, DL-valine, and DL-serine) in aqueous solutions at 298.15 K are studied and discussed. A salting-in effect is observed for all amino acids under investigation with all electrolytes used in the present study, except for DL-alanine and DL-valine in aqueous solutions containing sodium fluoride where a salting-out effect was observed. The orders of the effect of the nature and the charge of both the anions and the cations are: F- < CI - < Br- < NO-3 < SO 2-4 with both sodium and potassium cations; Na +


Idris S.A.M.,Omar Al-Mukhtar University
Journal of Colloid and Interface Science | Year: 2015

This paper describes studies of functionalized mesoporous silica employed as adsorbent for Mn(II) from aqueous solutions. The surface area of MCM-41 and diethylenetriamine functionalized-MCM-41 used in this study were 760 and 318m2g-1 (N2 adsorption). A strong dependence on pH in the Mn(II) adsorption capacity and best results were obtained at pH 6.5-7. The adsorption onto the diethylenetriamine functionalized-MCM-41 followed the pseudo-second-order kinetic model and the highest reaction rate 0.324min-1 was observed at low initial concentration 10ppm. The equilibrium data showed excellent correlation with the Langmuir isotherm model and the maximum adsorption capacity of Mn(II) reached 88.9mg/g for DETA-MCM-41 indicating that the adsorption occurs on a homogeneous surface by monolayer sorption without interaction between the adsorbed ions. These data contribute to the understanding of mechanisms involved in mesoporous silica and provide some practical clues to improve the adsorption efficiency (uptake capacity and kinetics) of Mn(II) ions. © 2014 Elsevier Inc.

Loading Omar Al-Mukhtar University collaborators
Loading Omar Al-Mukhtar University collaborators